SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/12210486

Prostate 2002 Sep 1 52 4 264-8

Download in:

View as

General Info

PMID
12210486